Hasnain Faheem

President & CEO, DirectorGossamer Bio, Inc. (GOSS) · full profile →Form 4 · filed Mar 20, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
20
0 non-derivative · 20 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 19, 2026Disposed to issuer(D)545K0
Mar 19, 2026Disposed to issuer(D)438K0
Mar 19, 2026Disposed to issuer(D)545K0
Mar 19, 2026Disposed to issuer(D)650K0
Mar 19, 2026Disposed to issuer(D)325K0
Mar 19, 2026Disposed to issuer(D)47K0
Mar 19, 2026Disposed to issuer(D)44K0
Mar 19, 2026Grant(A)1.7M1.7M
Mar 19, 2026Grant(A)1.5M1.5M
Mar 19, 2026Grant(A)1.3M1.3M
Mar 19, 2026Grant(A)438K438K
Mar 19, 2026Grant(A)545K545K
Mar 19, 2026Grant(A)545K545K
Mar 19, 2026Grant(A)650K650K
Mar 19, 2026Grant(A)325K325K
Mar 19, 2026Grant(A)47K47K
Mar 19, 2026Grant(A)44K44K
Mar 19, 2026Disposed to issuer(D)1.7M0
Mar 19, 2026Disposed to issuer(D)1.5M0
Mar 19, 2026Disposed to issuer(D)1.3M0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001352620-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: